Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer

被引：0
|
作者：
Sheng Zhang
Yongzhi Yang
Wenhao Weng
Bomin Guo
Guoxiang Cai
Yanlei Ma
Sanjun Cai
机构：
[1] Fudan University Shanghai Cancer Center,Department of Colorectal Surgery
[2] Fudan University,Department of Oncology, Shanghai Medical College
[3] Tongji University School of Medicine,Department of Clinical Laboratory, Yangpu Hospital
[4] Tongji University School of Medicine,Center for Translational Medicine, Yangpu Hospital
[5] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of Surgery
来源：
Journal of Experimental & Clinical Cancer Research | / 38卷
关键词：
BIRC3; 5-fluorouracil; Chemoresistance; Colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil
    Fahima Danesh Pouya
    Maria Gazouli
    Yousef Rasmi
    Dimitra Ioanna Lampropoulou
    Mohadeseh Nemati
    Molecular Biology Reports, 2022, 49 : 5165 - 5178
  • [42] Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
    Xie, Pan
    Mo, Jun-Luan
    Liu, Jin-Hong
    Li, Xi
    Tan, Li-Ming
    Zhang, Wei
    Zhou, Hong-Hao
    Liu, Zhao-Qian
    CELLULAR ONCOLOGY, 2020, 43 (06) : 989 - 1001
  • [43] Clinical Significance of 5-Fluorouracil Chemosensitivity Testing in Patients with Colorectal Cancer
    Ji, Woong Bae
    Um, Jun Won
    Ryu, Je Seock
    Hong, Kwang Dae
    Kim, Jung Sik
    Min, Byung Wook
    Joung, Sung Yeop
    Lee, Ju Han
    Kim, Young Sik
    ANTICANCER RESEARCH, 2017, 37 (05) : 2679 - 2682
  • [44] PHARMACOKINETICS OF 5-FLUOROURACIL IN COLORECTAL-CANCER PATIENTS RECEIVING INTERFERON
    PITTMAN, K
    PERREN, T
    WARD, U
    PRIMROSE, J
    SLEVIN, M
    PATEL, N
    SELBY, P
    ANNALS OF ONCOLOGY, 1993, 4 (06) : 515 - 516
  • [45] Fisetin and 5-fluorouracil: Effective combination for PIK3CA-mutant colorectal cancer
    Khan, Naghma
    Jajeh, Farah
    Eberhardt, Emily L.
    Miller, Devon D.
    Albrecht, Dawn M.
    Van Doorn, Rachel
    Hruby, Melissa D.
    Maresh, Morgan E.
    Clipson, Linda
    Mukhtar, Hasan
    Halberg, Richard B.
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (11) : 3022 - 3032
  • [46] ACTIVITY OF CONTINUOUS-INFUSION 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER CLINICALLY RESISTANT TO BOLUS 5-FLUOROURACIL
    MORI, A
    BERTOGLIO, S
    GUGLIELMI, A
    ASCHELE, C
    BOLLI, E
    TIXI, L
    ROSSO, R
    SOBRERO, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (02) : 179 - 180
  • [47] MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil
    Pouya, Fahima Danesh
    Gazouli, Maria
    Rasmi, Yousef
    Lampropoulou, Dimitra Ioanna
    Nemati, Mohadeseh
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (06) : 5165 - 5178
  • [48] Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
    Pan Xie
    Jun-Luan Mo
    Jin-Hong Liu
    Xi Li
    Li-Ming Tan
    Wei Zhang
    Hong-Hao Zhou
    Zhao-Qian Liu
    Cellular Oncology, 2020, 43 : 989 - 1001
  • [49] 5-Fluorouracil induces apoptosis of colorectal cancer cells
    Zhang, J. T.
    Zhou, W. L.
    He, C.
    Liu, T.
    Li, C. Y.
    Wang, L.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (01)
  • [50] Inhibition of NLRP3 by Fermented Quercetin Decreases Resistin-Induced Chemoresistance to 5-Fluorouracil in Human Colorectal Cancer Cells
    Lee, Ko-Chao
    Wu, Kuen-Lin
    Yen, Chia-Kung
    Chang, Shun-Fu
    Chen, Cheng-Nan
    Lu, Ying-Chen
    PHARMACEUTICALS, 2022, 15 (07)
12345